InvestorsHub Logo
Followers 9
Posts 368
Boards Moderated 0
Alias Born 09/19/2017

Re: None

Tuesday, 11/10/2020 5:21:59 PM

Tuesday, November 10, 2020 5:21:59 PM

Post# of 687267
NEW FILING: Notification of late filing of 10-Q

"Northwest Biotherapeutics, Inc. (the “Company”) was unable to file its Quarterly Report on Form 10-Q timely due to certain pending accounting and valuation matters such as those in connection with the acquisition of Flaskworks during the quarter, and due to subsequent events (after September 30) affecting the accounting for option awards during the quarter. The Company currently expects to file its report within the extension period."

https://www.sec.gov/Archives/edgar/data/1072379/000110465920123637/tm2035630d1_nt10q.htm

Also quoted:
"As a result of a large change in the fair value calculations for derivative liabilities, as well as other accruals, this quarter will reflect non-cash losses far larger than those reflected in Q3 of 2019."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News